On tuberculosis and COVID-19 co-infection

Eur Respir J. 2020 Aug 20;56(2):2002328. doi: 10.1183/13993003.02328-2020. Print 2020 Aug.

¹ Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
² Tuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain.
³ Centre Hospitalier Universitaire, Nantes, France.
⁴ Moscow Research and Clinical Center for TB Control, Moscow, Russian Federation.
⁵ Translational Research Unit, National Institute for Infectious Diseases "L. Spallanzani", IRCCS, Rome, Italy.
⁶ Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italia.
⁷ TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
⁸ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
⁹ Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
¹⁰ Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
¹¹ Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.

Abstract

COVID-19 may boost tuberculosis given infection and mortality, further studies are needed https://bit.ly/2Z2r5XO